AMED Amedisys Inc

Price (delayed)

$98.09

Market cap

$3.21B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.63

Enterprise value

$3.57B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
AMED's gross profit is up by 3.7% year-on-year
The gross margin has increased by 3% YoY
The quick ratio has increased by 4.2% QoQ but it has decreased by 3.9% YoY
The net income has shrunk by 118% YoY and by 111% QoQ
AMED's EPS has plunged by 118% YoY and by 110% from the previous quarter

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.68M
Market cap
$3.21B
Enterprise value
$3.57B
Valuations
Price to book (P/B)
2.94
Price to sales (P/S)
1.42
EV/EBIT
55.14
EV/EBITDA
29.02
EV/Sales
1.58
Earnings
Revenue
$2.25B
EBIT
$64.68M
EBITDA
$122.91M
Free cash flow
$97.88M
Per share
EPS
-$0.63
Free cash flow per share
$3
Book value per share
$33.31
Revenue per share
$68.91
TBVPS
$22.76
Balance sheet
Total assets
$2.09B
Total liabilities
$947.22M
Debt
$481.82M
Equity
$1.09B
Working capital
$41.59M
Liquidity
Debt to equity
0.44
Current ratio
1.09
Quick ratio
0.99
Net debt/EBITDA
2.94
Margins
EBITDA margin
5.5%
Gross margin
44.4%
Net margin
-0.9%
Operating margin
6.5%
Efficiency
Return on assets
-1%
Return on equity
-2%
Return on invested capital
11%
Return on capital employed
4%
Return on sales
2.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
-0.23%
1 week
0.86%
1 month
6.84%
1 year
8.39%
YTD
3.19%
QTD
6.85%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.25B
Gross profit
$999.37M
Operating income
$145.63M
Net income
-$20.59M
Gross margin
44.4%
Net margin
-0.9%
The company's net margin has shrunk by 125% QoQ and by 118% YoY
The net income has shrunk by 118% YoY and by 111% QoQ
The company's operating margin fell by 19% YoY and by 7% QoQ
AMED's operating income is down by 18% year-on-year and by 7% since the previous quarter

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
N/A
P/B
2.94
P/S
1.42
EV/EBIT
55.14
EV/EBITDA
29.02
EV/Sales
1.58
AMED's EPS has plunged by 118% YoY and by 110% from the previous quarter
The P/B is 52% less than the 5-year quarterly average of 6.1
AMED's equity is up by 2% since the previous quarter
The P/S is 41% less than the 5-year quarterly average of 2.4

Efficiency

How efficient is Amedisys business performance
The ROE has plunged by 122% from the previous quarter and by 118% YoY
The ROA has dropped by 118% year-on-year and by 100% since the previous quarter
AMED's ROS has plunged by 64% YoY and by 9% from the previous quarter
The ROIC has plunged by 57% YoY and by 8% from the previous quarter

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 121% higher than its total liabilities
The company's total liabilities rose by 16% YoY
AMED's total assets is up by 7% YoY
The company's debt is 56% lower than its equity
The debt to equity has contracted by 4.3% from the previous quarter and by 2.2% YoY
AMED's equity is up by 2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.